Holen Sie sich die Stockscreener-App
3.38
1.50%
0.05
Schlusskurs vom Vortag:
$3.33
Offen:
$3.4
24-Stunden-Volumen:
6,581
Relative Volume:
0.01
Marktkapitalisierung:
$3.56M
Einnahmen:
$67,500
Nettoeinkommen (Verlust:
$-7.33M
KGV:
-0.00211
EPS:
-1602.9371
Netto-Cashflow:
$-6.66M
1W Leistung:
+3.36%
1M Leistung:
+31.01%
6M Leistung:
-56.22%
1J Leistung:
-81.72%
1-Tages-Spanne:
$3.35
$3.4244
1-Wochen-Bereich:
$3.165
$3.52
52-Wochen-Spanne:
$2.3401
$31.05
Aclarion Inc Stock (ACON) Company Profile
Firmenname
Aclarion Inc
Sektor
Branche
Telefon
833 275 2266
Adresse
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
3.38 | 3.51M | 67,500 | -7.33M | -6.66M | -1,602.94 |
|
VEEV
Veeva Systems Inc
|
178.91 | 29.72B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.48 | 8.85B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
37.63 | 7.42B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
75.78 | 6.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.14 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Aclarion Inc Aktie (ACON) Neueste Nachrichten
Aclarion CEO to Present AI-Powered Back Pain Diagnostic Technology at Leading MedTech Conference - citybuzz -
Aclarion CEO Brent Ness to Attend LSI USA 2026 - Bitget
Aclarion, Inc. CEO Brent Ness to Attend LSI USA 2026 to Discuss NOCISCAN and Industry Partnerships - Quiver Quantitative
Quarterly Risk: Is Aclarion Inc Equity Warrant stock undervalued right nowQuarterly Profit Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Decliners Report: Is Aclarion Inc Equity Warrant attractive for institutional investorsTrade Volume Report & Growth-Oriented Investment Plans - baoquankhu1.vn
What is Aclarion Inc Equity Warrants 5 year growth outlookJuly 2025 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Will Aclarion Inc. stock benefit from upcoming earnings reports2026 Chart Watch & Proven Capital Preservation Methods - Naître et grandir
Aug EndMonth: How Aclarion Inc. Equity Warrant stock reacts to job market dataTrade Analysis Report & Accurate Buy Signal Notifications - Naître et grandir
Dividend Watch: Will Aclarion Inc Equity Warrant outperform during market rallies2025 Analyst Calls & Breakout Confirmation Alerts - baoquankhu1.vn
Analyst Calls: Will Aclarion Inc Equity Warrant outperform during market ralliesIndex Update & Consistent Return Strategy Ideas - baoquankhu1.vn
Bank Watch: Does Five Below Inc stock have upside surprise potentialMarket Activity Recap & Safe Entry Momentum Tips - baoquankhu1.vn
Retail Trends: Whats next for CalciMedica Inc stock2025 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn
ACON PE Ratio & Valuation, Is ACON Overvalued - Intellectia AI
Activity Recap: Is Tidewater Inc forming a breakout patternWeekly Market Outlook & Weekly Top Stock Performers List - baoquankhu1.vn
ACON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Volatility Watch: Is Aclarion Inc still a buy after recent gainsTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn
Trading Recap: Whats the outlook for Aclarion Inc Equity Warrants sectorJuly 2025 Summary & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Investor Mood: Is Aclarion Inc Equity Warrant still a buy after recent gains - baoquankhu1.vn
Market Wrap: Is Aclarion Inc Equity Warrant stock undervalued right now2025 Big Picture & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Can Aclarion Inc. Equity Warrant stock continue upward trend2025 Key Lessons & Safe Entry Momentum Stock Tips - mfd.ru
US Market Wrap: Should I hold or sell Aclarion Inc. Equity Warrant now2025 Short Interest & Stepwise Entry and Exit Trade Signals - mfd.ru
Is Aclarion Inc. stock positioned for long term growthWeekly Earnings Recap & Consistent Income Trade Ideas - mfd.ru
ACON Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ACON Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Can Aclarion Inc. weather a recessionNew Guidance & Verified Stock Trade Ideas - mfd.ru
What are Aclarion Inc.’s earnings expectationsWeekly Stock Report & Reliable Price Action Trade Plans - mfd.ru
Earnings Beat: Is TriSalus Life Sciences Inc Equity Warrant a strong growth stock2025 Growth vs Value & Short-Term Trading Alerts - baoquankhu1.vn
What’s the outlook for Aclarion Inc. Equity Warrant’s sectorWeekly Investment Report & Low Drawdown Trading Strategies - mfd.ru
NeuroOne Medical Technologies (NASDAQ:NMTC) versus Aclarion (NASDAQ:ACON) Head to Head Contrast - Defense World
How does Aclarion Inc. Equity Warrant correlate with NasdaqWeekly Investment Summary & Daily Chart Pattern Signals - mfd.ru
How does Aclarion Inc. compare to its peersInsider Selling & Precise Trade Entry Recommendations - mfd.ru
Market Leaders: Whats the outlook for Aclarion Inc Equity Warrants sectorWeekly Profit Report & Short-Term High Return Ideas - baoquankhu1.vn
Analyst Upgrade: Does SPOT have declining or rising EPSOil Prices & Community Trade Idea Sharing - baoquankhu1.vn
Aclarion secures $10.4M for back-pain diagnostic technology - BizWest
Aclarion Publishes 2026 Shareholder Letter from the Chairman - The Globe and Mail
Aclarion, Inc. Announces Strong Financial Position and Path to CLARITY Trial Milestones Ahead of 2026 - Quiver Quantitative
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes - Asianet Newsable
Aclarion CEO Outlines 2026 Execution Plan Focused on Reimbursement and Adoption - intellectia.ai
Aclarion CEO Bets On Bigger AI MedTech’s Playbook To Revive Sagging Stock - Stocktwits
Aclarion partners with Source Healthcare to expand Nociscan availability By Investing.com - Investing.com Nigeria
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation - Ortho Spine News
Aclarion Expands Nociscan Availability in Greater Los Angeles - Intellectia AI
Aclarion partners with Source Healthcare to expand Nociscan availability - Investing.com
Aclarion Expands Nociscan Availability in Greater Los Angeles Area Through Partnership with Source Healthcare - Quiver Quantitative
LA pain clinic adds Aclarion’s noninvasive alternative to spinal injections - stocktitan.net
Healthcare Stocks To Keep An Eye OnJanuary 8th - MarketBeat
Is Aclarion Inc. Equity Warrant stock suitable for long term investingJuly 2025 Volume & Low Drawdown Investment Strategies - mfd.ru
Investment Recap: What is Aclarion Inc Equity Warrants 5 year growth outlookWatch List & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Will Aclarion Inc. Equity Warrant outperform tech stocksCPI Data & Weekly Setup with ROI Potential - mfd.ru
Short Interest in Aclarion, Inc. (NASDAQ:ACON) Rises By 379.3% - Defense World
Investment Review: How do insiders feel about Nova Minerals Limited Depositary ReceiptJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
Finanzdaten der Aclarion Inc-Aktie (ACON)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):